US Stock MarketDetailed Quotes

DRIO DarioHealth

Watchlist
  • 0.720
  • +0.046+6.85%
Close Nov 27 16:00 ET
24.56MMarket Cap-774P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Jaguar8
    Jaguar8
    Nov 21 07:34
    NEWS
    $DarioHealth (DRIO.US)$
    Dario Signs Four New Employer Contracts Across Full Product Suite
    DarioHealth (Nasdaq: DRIO) has secured four new self-insured employer contracts, expected to go live in Q1 2025. These contracts cover Dario's complete platform suite, with clients opting for multi-condition offerings rather than single-condition solutions. The company projects to achieve approximately 25 new client signings in 2024, representing a 35% growth in client base compared to 2023.
    These new ...
    Jaguar8
    Jaguar8
    Sep 10 07:32
    NEWS
    $DarioHealth (DRIO.US)$
    Dario Publishes New Research Revealing How Physical Activity Mediates the Impact of Depression on Blood Glucose Levels in Individuals with Diabetes or Prediabetes
    DarioHealth Corp. (Nasdaq: DRIO) has published a new study in Frontiers in Endocrinology, demonstrating the effectiveness of its cardiometabolic solution for individuals with diabetes or prediabetes and depression. The research, involving 989 users over 12 months, reveals:
    Members with depression showed highe...
    NRAO
    NRAO
    Sep 3 10:37
    $DarioHealth (DRIO.US)$ holding this for almost 4 months
    Trytosaveabit
    Trytosaveabit
    Jul 16 07:32
    Update
    $DarioHealth (DRIO.US)$ Reuters· just
    DarioHealth-New Contract With National Employer to Provide Cardiometabolic Solution With Integrated Support for Glp-1S to Employees Beginning in Q3
    Jaguar8
    Jaguar8
    Jun 25 07:30
    NEWS
    $DarioHealth (DRIO.US)$
    Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1
    New research presented by DarioHealth at the 84th Annual ADA Scientific Sessions demonstrates the efficacy of their digital health platform in sustaining behavior change for members taking GLP-1 medications. Data over a 12-month period show significant improvements in healthy lifestyle tracking and blood glucose control. Notably, 31% of Type 2 diabetes members achieved results ...
Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data